Latham & Watkins represented Boston Scientific Corporation in the transaction, and Wilson Sonsini Goodrich & Rosati represented Silk Road Medical. Boston Scientific Corporation (“Boston Scientific”) (NYSE:...
Boston Scientific’s $1.26 Billion Acquisition of Silk Road
Boston Scientific’s $3.7 Billion Acquisition of Axonics
Shearman & Sterling represented Boston Scientific Corporation in the transaction, and K&L Gates represented Axonics, Inc. Boston Scientific Corporation (NYSE: BSX) announced it has entered into a definitive...
Boston Scientific’s $850 Million Acquisition of Relievant MedSystems
Faegre Drinker advised Boston Scientific, and Latham & Watkins advised Relievant MedSystems on the deal. Boston Scientific Corporation (NYSE: BSX) announced it has entered into a...
Boston Scientific v. Cook Medical
Arnold & Porter advised Boston Scientific on the deal. Boston Scientific obtained a $158 million litigation victory. The case began in 2015 when Boston Scientific sued Cook Medical...
Boston Scientific’s Acquisition of Apollo Endosurgery
Cooley LLP advised Apollo Endosurgery on the deal, while Shearman & Sterling advised Boston Scientific Corporation. Apollo Endosurgery, a medical device company, signed the agreement to be...
Boston Scientific’s Acquisition of Obsidio
Wilson Sonsini Goodrich & Rosati advised Obsidio on the deal, while Latham & Watkins represented Boston Scientific Corporation. Boston Scientific Corporation announced the acquisition of Obsidio, Inc.,...
Boston Scientific’s $1.75 Billion Acquisition of Baylis Medical Company
Shearman & Sterling advised Boston Scientific Corporation on the acquisition of Baylis Medical Company, assisted by BCF Business Law, in collaboration with Cooley LLP (U.S. lead...
Boston Scientific’s $1.07 Billion Acquisition of Lumenis Surgical Business
Ropes & Gray represented an affiliate of Baring Private Equity Asia in the transaction, while Yigal Arnon & Co. and Latham & Watkins represented Boston Scientific,...